These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33458928)

  • 1. Pharmacological Therapy Determines the Gut Microbiota Modulation by a Pomegranate Extract Nutraceutical in Metabolic Syndrome: A Randomized Clinical Trial.
    Cortés-Martín A; Iglesias-Aguirre CE; Meoro A; Selma MV; Espín JC
    Mol Nutr Food Res; 2021 Mar; 65(6):e2001048. PubMed ID: 33458928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The gut microbiota metabolism of pomegranate or walnut ellagitannins yields two urolithin-metabotypes that correlate with cardiometabolic risk biomarkers: Comparison between normoweight, overweight-obesity and metabolic syndrome.
    Selma MV; González-Sarrías A; Salas-Salvadó J; Andrés-Lacueva C; Alasalvar C; Örem A; Tomás-Barberán FA; Espín JC
    Clin Nutr; 2018 Jun; 37(3):897-905. PubMed ID: 28347564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Endotoxemia Marker Lipopolysaccharide-Binding Protein is Reduced in Overweight-Obese Subjects Consuming Pomegranate Extract by Modulating the Gut Microbiota: A Randomized Clinical Trial.
    González-Sarrías A; Romo-Vaquero M; García-Villalba R; Cortés-Martín A; Selma MV; Espín JC
    Mol Nutr Food Res; 2018 Jun; 62(11):e1800160. PubMed ID: 29665619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering according to urolithin metabotype explains the interindividual variability in the improvement of cardiovascular risk biomarkers in overweight-obese individuals consuming pomegranate: A randomized clinical trial.
    González-Sarrías A; García-Villalba R; Romo-Vaquero M; Alasalvar C; Örem A; Zafrilla P; Tomás-Barberán FA; Selma MV; Espín JC
    Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27879044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk between dietary pomegranate and gut microbiota: evidence of health benefits.
    Yin Y; Martínez R; Zhang W; Estévez M
    Crit Rev Food Sci Nutr; 2024; 64(27):10009-10035. PubMed ID: 37335106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCF7L2-rs7903146 polymorphism modulates the effect of artichoke leaf extract supplementation on insulin resistance in metabolic syndrome: a randomized, double-blind, placebo-controlled trial.
    Ebrahimi-Mameghani M; Asghari-Jafarabadi M; Rezazadeh K
    J Integr Med; 2018 Sep; 16(5):329-334. PubMed ID: 30177026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urolithin Metabotypes Can Determine the Modulation of Gut Microbiota in Healthy Individuals by Tracking Walnuts Consumption over Three Days.
    García-Mantrana I; Calatayud M; Romo-Vaquero M; Espín JC; Selma MV; Collado MC
    Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pomegranate peel extract ameliorates the severity of experimental autoimmune encephalomyelitis via modulation of gut microbiota.
    Lu XY; Han B; Deng X; Deng SY; Zhang YY; Shen PX; Hui T; Chen RH; Li X; Zhang Y
    Gut Microbes; 2020 Nov; 12(1):1857515. PubMed ID: 33382357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal Simulation Model TWIN-SHIME Shows Differences between Human Urolithin-Metabotypes in Gut Microbiota Composition, Pomegranate Polyphenol Metabolism, and Transport along the Intestinal Tract.
    García-Villalba R; Vissenaekens H; Pitart J; Romo-Vaquero M; Espín JC; Grootaert C; Selma MV; Raes K; Smagghe G; Possemiers S; Van Camp J; Tomas-Barberan FA
    J Agric Food Chem; 2017 Jul; 65(27):5480-5493. PubMed ID: 28616977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of Lipoprotein Profile and Metabolic Endotoxemia by a Lifestyle Intervention That Modifies the Gut Microbiota in Subjects With Metabolic Syndrome.
    Guevara-Cruz M; Flores-López AG; Aguilar-López M; Sánchez-Tapia M; Medina-Vera I; Díaz D; Tovar AR; Torres N
    J Am Heart Assoc; 2019 Sep; 8(17):e012401. PubMed ID: 31451009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pomegranate peel polyphenols reduce chronic low-grade inflammatory responses by modulating gut microbiota and decreasing colonic tissue damage in rats fed a high-fat diet.
    Zhao R; Long X; Yang J; Du L; Zhang X; Li J; Hou C
    Food Funct; 2019 Dec; 10(12):8273-8285. PubMed ID: 31720661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycerol-Monolaurate-Mediated Attenuation of Metabolic Syndrome is Associated with the Modulation of Gut Microbiota in High-Fat-Diet-Fed Mice.
    Zhao M; Cai H; Jiang Z; Li Y; Zhong H; Zhang H; Feng F
    Mol Nutr Food Res; 2019 Sep; 63(18):e1801417. PubMed ID: 31318165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota Profiles of Treated Metabolic Syndrome Patients and their Relationship with Metabolic Health.
    Wutthi-In M; Cheevadhanarak S; Yasom S; Kerdphoo S; Thiennimitr P; Phrommintikul A; Chattipakorn N; Kittichotirat W; Chattipakorn S
    Sci Rep; 2020 Jun; 10(1):10085. PubMed ID: 32572149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Habitual dietary fibre intake influences gut microbiota response to an inulin-type fructan prebiotic: a randomised, double-blind, placebo-controlled, cross-over, human intervention study.
    Healey G; Murphy R; Butts C; Brough L; Whelan K; Coad J
    Br J Nutr; 2018 Jan; 119(2):176-189. PubMed ID: 29307330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blueberry polyphenols extract as a potential prebiotic with anti-obesity effects on C57BL/6 J mice by modulating the gut microbiota.
    Jiao X; Wang Y; Lin Y; Lang Y; Li E; Zhang X; Zhang Q; Feng Y; Meng X; Li B
    J Nutr Biochem; 2019 Feb; 64():88-100. PubMed ID: 30471564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urolithin A production drives the effects of pomegranate on the gut microbial metabolism of bile acids and cholesterol in mild dyslipidaemic overweight and obese individuals.
    Cortés-Martín A; Iglesias-Aguirre CE; Marín A; Romo-Vaquero M; Vallejo F; Espín JC; Victoria Selma M
    Food Funct; 2024 Mar; 15(5):2422-2432. PubMed ID: 38329279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of heritability and host genetics on the gut microbiota and metabolic syndrome.
    Lim MY; You HJ; Yoon HS; Kwon B; Lee JY; Lee S; Song YM; Lee K; Sung J; Ko G
    Gut; 2017 Jun; 66(6):1031-1038. PubMed ID: 27053630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-chain fatty acids accompanying changes in the gut microbiome contribute to the development of hypertension in patients with preeclampsia.
    Chang Y; Chen Y; Zhou Q; Wang C; Chen L; Di W; Zhang Y
    Clin Sci (Lond); 2020 Jan; 134(2):289-302. PubMed ID: 31961431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unveiling metabotype clustering in resveratrol, daidzein, and ellagic acid metabolism: Prevalence, associated gut microbiomes, and their distinctive microbial networks.
    Eduardo Iglesias-Aguirre C; Romo-Vaquero M; Victoria Selma M; Carlos Espín J
    Food Res Int; 2023 Nov; 173(Pt 2):113470. PubMed ID: 37803793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients.
    Nuñez-Sánchez MA; García-Villalba R; Monedero-Saiz T; García-Talavera NV; Gómez-Sánchez MB; Sánchez-Álvarez C; García-Albert AM; Rodríguez-Gil FJ; Ruiz-Marín M; Pastor-Quirante FA; Martínez-Díaz F; Yáñez-Gascón MJ; González-Sarrías A; Tomás-Barberán FA; Espín JC
    Mol Nutr Food Res; 2014 Jun; 58(6):1199-211. PubMed ID: 24532260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.